The biomedical start-ups in the BioRegion of Catalonia currently have almost 20 therapies in the clinical phase. Some of these therapies may reach patients by 2025. What might the next made-in-Catalonia drugs be?
Every day, organizations waste hours looking for data and writing up reports on issues that someone else has already written about. The healthcare sector is no exception: we at Biocat are now offering a compilation of essential resources which can save you lots of time.
